Patents by Inventor Robert Allen Britton

Robert Allen Britton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic for the prevention and/or treatment of weight gain and/or diabetes
    Patent number: 11028141
    Abstract: Embodiments of the disclosure encompass compositions and methods for the treatment of medical conditions in which increases in GLP-1 are beneficial to an individual. In specific embodiments, the disclosure concerns certain peptides that are capable of inducing GLP-1 production in an individual with a medical condition, such as type II diabetes or obesity. In other cases, an individual is not obese or overweight but is provided the peptide in an effort to reduce weight from fat.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: June 8, 2021
    Assignee: Baylor College of Medicine
    Inventors: Robert Allen Britton, Catherine Tomaro-Duchesneau
  • ENGINEERING NOVEL ENTEROID MODELS FOR UNDERSTANDING HUMAN ENTERIC DISEASE
    Publication number: 20200269230
    Abstract: An anaerobic chamber system to evaluate human enteric disease is described herein that can be used to test therapeutic components. In specific embodiments, the anaerobic chamber is used to determine the effect of one or more bacterial communities on ex vivo enteroid cultures. In one application, the anaerobic chamber system is used to determine the efficacy of therapeutic components in ameliorating human enteric disease using personalized medicine.
    Type: Application
    Filed: October 26, 2018
    Publication date: August 27, 2020
    Inventors: Tatiana Y. Fofanova, Jennifer Auchtung, Reid Laurence Wilson, Christopher Stewart, Joseph Petrosino, Robert Allen Britton, Jane Grande-Allen, Noah F. Shroyer, Mary K. Estes
  • DEVELOPMENT OF MICROBIAL BIOSENSORS FOR INTESTINAL INFLAMMATION
    Publication number: 20200209261
    Abstract: Embodiments of the disclosure include systems, methods, and compositions for detection of imminent onset of a symptom of a gut inflammation medical condition. The disclosure also concerns microbial biosensors that detect a marker in the gut that is predictive of onset of at least one symptom of inflammatory bowel disease (IBD), for example, and such a sensor may include a promoter sensitive to the marker that is linked to expression of a detectable readout, such as in the feces of the individual with IBD.
    Type: Application
    Filed: May 11, 2018
    Publication date: July 2, 2020
    Applicant: Baylor College of Medicine
    Inventors: Robert Allen Britton, Jeffrey David Galley
  • COMMENSAL BACTERIA AS NOVEL TREATMENT FOR DRY EYE AND SJOGREN SYNDROME
    Publication number: 20200054697
    Abstract: Embodiments of the disclosure encompass methods of treating or preventing an autoimmune disease in an individual. In particular cases, methods comprise administering for delivery to an individual a composition of microbiota. In certain cases, the composition comprises a population of one or more microbiota capable of producing one or more short-chain fatty acids.
    Type: Application
    Filed: April 11, 2018
    Publication date: February 20, 2020
    Inventors: Cintia S. De Paiva, Stephen C. Pflugfelder, Robert Allen Britton
  • Selection and use of lactic acid bacteria preventing bone loss in mammals
    Patent number: 10537598
    Abstract: The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strains capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: January 21, 2020
    Assignees: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY, BIOGAIA AB
    Inventors: Eamonn Connolly, Robert Allen Britton, Laura Rae McCabe
  • THERAPEUTIC FOR THE PREVENTION AND/OR TREATMENT OF WEIGHT GAIN AND/OR DIABETES
    Publication number: 20190270790
    Abstract: Embodiments of the disclosure encompass compositions and methods for the treatment of medical conditions in which increases in GLP-1 are beneficial to an individual. In specific embodiments, the disclosure concerns certain peptides that are capable of inducing GLP-1 production in an individual with a medical condition, such as type II diabetes or obesity. In other cases, an individual is not obese or overweight but is provided the peptide in an effort to reduce weight from fat.
    Type: Application
    Filed: November 9, 2017
    Publication date: September 5, 2019
    Inventors: Robert Allen Britton, Catherine Tomaro-Duchesneau
  • Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals
    Publication number: 20190142879
    Abstract: The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strains capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
    Type: Application
    Filed: January 23, 2019
    Publication date: May 16, 2019
    Inventors: Eamonn Connolly, Robert Allen Britton, Laura Rae McCabe
  • Selection and use of lactic acid bacteria preventing bone loss in mammals
    Patent number: 10232001
    Abstract: The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strain's capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: March 19, 2019
    Assignees: BioGaia AB, Board of Trustees of Michigan State University
    Inventors: Eamonn Connolly, Robert Allen Britton, Laura Rae McCabe
  • Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals
    Publication number: 20180200313
    Abstract: The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strain's capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
    Type: Application
    Filed: March 12, 2018
    Publication date: July 19, 2018
    Applicants: BIOGAIA AB, MICHIGAN STATE UNIVERSITY
    Inventors: Eamonn Connolly, Robert Allen Britton, Laura Rae McCabe
  • Selection and use of lactic acid bacteria preventing bone loss in mammals
    Patent number: 9968643
    Abstract: The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strain's capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: May 15, 2018
    Assignees: BIOGAIA AB, MICHIGAN STATE UNIVERSITY
    Inventors: Eamonn Connolly, Robert Allen Britton, Laura Rae McCabe
  • Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals
    Publication number: 20170128501
    Abstract: The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strain's capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
    Type: Application
    Filed: October 21, 2016
    Publication date: May 11, 2017
    Applicants: BIOGAIA AB, Michigan State University
    Inventors: Eamonn Connolly, Robert Allen Britton, Laura Rae McCabe
  • Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals
    Publication number: 20150150917
    Abstract: The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strain's capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
    Type: Application
    Filed: June 4, 2013
    Publication date: June 4, 2015
    Applicants: Michigan State University, BIOGAIA AB
    Inventors: Eamonn Connolly, Robert Allen Britton, II, Laura Rae McCabe
  • Ruminant feed and method for making
    Patent number: 5789001
    Abstract: A ruminally inert fat for a ruminant feed is made by applying reducing sugars to oilseed meats and heating to induce non-enzymatic browning. The process is controlled to ensure penetration of the reducing sugars into the interior of cracked oilseed meat prior to browning. The browning reaction renders the protein which surrounds the oil resistant to rumen bacterial degradation to thereby encapsulate the oil in a protective matrix.
    Type: Grant
    Filed: June 9, 1995
    Date of Patent: August 4, 1998
    Assignee: University of Nebraska
    Inventors: Terry James Klopfenstein, Thomas Stephen Winowiski, Robert Allen Britton, deceased